arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Guardant Health, Inc.

GH Health Care Medical Specialities
$163.00
▲ +1.0% Today
as of Sep 4, 16:49 ET
Last 30 days +12.39% Jul 28 → Sep 04
$141.44 $149.35 $157.27 $165.19 $173.10 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$159.85
High
$164.84
Low
$154.00
Volume
$2M
Avg Vol
$2M
Mkt Cap
$21.1B
P/E (TTM)
—
Beta
—
52w High
$176.58
52w Low
$53.40
Div Yield
—
Shares Out
$134M

Recent Press Releases & News last 60 days · 25 items

Sep 5 · 00:07 Insider Monkey
Guardant Health Faces a $245 Million Patent Judgment, But Its Newer Tests Could Offer Protection
Sep 4 · 22:10 PR Business Wire
Guardant Health Announces Landmark FDA Approval of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s ETCAMAH™ (camizestrant) in Advanced Breast Cancer
Sep 1 · 13:03 MT Newswires
Guardant Health Expands Shield Blood Test Coverage Through Carelon
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$53
$177
89% of range
Avg surprise (last 3)
-6.1%
Avg reaction (last 2)
-2.3%
50% positive
Latest IV / EM
56%
EM ±8.8% · $160 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.30$-1.14$-0.99$-0.83$-0.67 Actual $-1.30Actual $-0.67Actual $-0.73Actual $-0.94Actual $-0.84Actual $-0.88Actual $-0.77Est $-0.78Actual $-0.79Est $-0.79Actual $-0.74Actual $-0.85Est $-0.71Actual $-0.90 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-120M$-2M$116M$234M$352M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.90 — — — — financials
Thu May 7, 2026Mar/2026 $-0.85 $-0.71 -19.7% -10.4% +0.0% earnings
Tue Sep 30, 2025Sep 2025 $-0.74 — — — — financials
Wed Jul 30, 2025Jun/2025 $-0.79 $-0.79 0.0% — — earnings
Wed Apr 30, 2025Mar/2025 $-0.77 $-0.78 +1.3% — -4.6% earnings
Mon Sep 30, 2024Sep 2024 $-0.88 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.84 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.94 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.73 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.67 — — — — financials
Fri Mar 31, 2023Mar 2023 $-1.30 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$335M$302M—$265M$232M$203M—$191M
Cost of revenue$116M$105M—$94M$81M$75M—$74M
Gross profit————————
Operating income$-129M$-121M—$-99M$-106M$-111M—$-117M
Net income$-120M$-112M—$-93M$-100M$-95M—$-108M
EPS (diluted)$-0.90$-0.85—$-0.74$-0.80$-0.77—$-0.88

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$1.05B$989M$378M$580M$629M$699M$526M$585M
Inventory$105M$84M$86M$90M$84M$77M$71M$72M
Total current assets$1.36B$1.37B$1.47B$829M$883M$927M$1.06B$1.23B
Total assets$1.91B$1.92B$2.01B$1.28B$1.33B$1.34B$1.49B$1.54B
Long-term debt$1.50B$1.50B$1.50B$1.11B$1.12B$1.12B$1.14B—
Total liabilities$2.14B$2.10B$2.11B$1.63B$1.64B$1.60B$1.63B$1.60B
Total equity$-223M$-181M$-99M$-354M$-305M$-251M$-140M$-60M

Implied volatility — last 90 days

40%59%78%98%117% Jun 07 — IV 59% · EM ±8.2%Jun 08 — IV 49% · EM ±6.5%Jun 09 — IV 53% · EM ±6.6%Jun 10 — IV 60% · EM ±7.0%Jun 11 — IV 60% · EM ±6.6%Jun 12 — IV 52% · EM ±5.3%Jun 15 — IV 60% · EM ±4.4%Jun 16 — IV 75% · EM ±4.4%Jun 17 — IV 76% · EM ±3.2%Jun 19 — IV 53% · EM ±11.7%Jun 22 — IV 57% · EM ±11.9%Jun 23 — IV 55% · EM ±11.3%Jun 24 — IV 56% · EM ±11.1%Jun 25 — IV 52% · EM ±10.2%Jun 26 — IV 52% · EM ±10.0%Jun 29 — IV 54% · EM ±9.6%Jun 30 — IV 52% · EM ±9.0%Jul 01 — IV 53% · EM ±8.9%Jul 02 — IV 48% · EM ±7.8%Jul 03 — IV 50% · EM ±7.8%Jul 06 — IV 57% · EM ±7.8%Jul 07 — IV 52% · EM ±6.8%Jul 08 — IV 55% · EM ±6.8%Jul 09 — IV 55% · EM ±6.6%Jul 10 — IV 50% · EM ±5.5%Jul 13 — IV 65% · EM ±5.4%Jul 14 — IV 74% · EM ±5.3%Jul 15 — IV 79% · EM ±4.6%Jul 16 — IV 78% · EM ±3.3%Jul 20 — IV 67% · EM ±15.9%Jul 21 — IV 68% · EM ±15.8%Jul 22 — IV 66% · EM ±15.2%Jul 23 — IV 67% · EM ±15.2%Jul 24 — IV 68% · EM ±15.0%Jul 27 — IV 75% · EM ±15.6%Jul 28 — IV 75% · EM ±15.4%Jul 29 — IV 78% · EM ±15.6%Jul 30 — IV 78% · EM ±15.2%Jul 31 — IV 55% · EM ±10.6%Aug 03 — IV 56% · EM ±9.9%Aug 04 — IV 50% · EM ±8.7%Aug 05 — IV 47% · EM ±7.8%Aug 06 — IV 49% · EM ±7.9%Aug 07 — IV 47% · EM ±7.3%Aug 10 — IV 51% · EM ±7.0%Aug 11 — IV 46% · EM ±6.1%Aug 12 — IV 47% · EM ±5.9%Aug 13 — IV 50% · EM ±5.9%Aug 14 — IV 40% · EM ±4.5%Aug 17 — IV 52% · EM ±4.4%Aug 18 — IV 52% · EM ±3.8%Aug 19 — IV 58% · EM ±3.4%Aug 20 — IV 117% · EM ±4.9%Aug 24 — IV 47% · EM ±9.7%Aug 25 — IV 50% · EM ±10.2%Aug 26 — IV 48% · EM ±9.5%Aug 27 — IV 48% · EM ±9.4%Aug 28 — IV 53% · EM ±10.1%Aug 31 — IV 52% · EM ±9.2%Sep 01 — IV 51% · EM ±8.7%Sep 02 — IV 49% · EM ±8.2%Sep 03 — IV 52% · EM ±8.4%Sep 04 — IV 56% · EM ±8.8%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in